F2G Investors

15 investors on Angel Roster list F2G in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name F2G can appear together.

Investors listed
15
With verified email
53%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 F2G investors

The most complete profiles first. Showing 15 of 15.

  • Peter BainesVerified

    Venture Capital, Investor · United Kingdom

    SeedHealth CareE-commerceCybersecurityDeepTech

    Portfolio: Catalyst Biosciences, Vitrue, Am-Beo, Thiakis and 53 more

    Verified email available

  • Sunny ReddyVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Aftab KheraniVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Andrew SchiffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more

    Verified email available

  • Catherine PoulinVerified

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Verified email available

  • Eric AguiarVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Josh BilenkerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Robert WenzelVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Verified email available

  • Todd BradyVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: F2G, UNUM Therapeutics, Avidity Biosciences, Avrobio and 10 more

    Contact details available

  • Alain J. Gilbert

    Private Equity Firm, Investment Partner · France

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Marc

    Private Equity Firm, Investment Partner · Canada

    Health CareInvestment ManagementLife ScienceEmerging Markets

    Portfolio: HighLife, CurvaFix, Aprea, F2G and 19 more

    Contact details available

  • Scott Braunstein

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Sophie Phillips

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more

    Contact details available

  • Coen Teulings

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Flayr, F2G, Cyclacel Pharmaceuticals, DoveConviene and 5 more

    Contact details available

  • Simona Heidempergher

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareTelecommunicationsGeneticsE-commerce

    Portfolio: Flayr, F2G, Cyclacel Pharmaceuticals, DoveConviene and 5 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many F2G investors are on Angel Roster?

Angel Roster lists 15 F2G investors. 8 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (14), Venture Capital Firms (11) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do F2G investors invest in?

Among those that list a stage, the most common are Seed (2).

Where are F2G investors based?

Most are based in the United States (9), the United Kingdom (3) and Canada (2).

Which companies have F2G investors backed?

The most-backed portfolio companies among them are Avrobio (9), Versartis (9), Spirox (8), Arcus Biosciences (8) and VYNE Therapeutics (8).

How do I contact F2G investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.